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ABSTRACT 
Background: It is difficult to diagnose Mycobacterium tuberculosis infection due to a lack of rapid, sensitive, and 
specific tests. Newer methods, which are easy and reliable, are required to diagnose TB at an early stage. Our aim is to 
evaluate the polymerase chain reaction (PCR) technique, using primers directed against the IS6110 gene, for the 
detection of M. tuberculosis in the sputum samples, and calculate the sensitivity and specificity of PCR. 
Patients and methods: A total of 248 sputum samples from patients suspected of mycobacterial diseases were studied. 
DNA was extracted by boiling method. IS6110 PCR method by a specific pair of primers designed to amplify 123bp and 
245bp sequences of the insertion sequence, 6110, in the M. tuberculosis genome was used to analyze sputum samples.  
Results: Totally, 32 (12.9%) samples had positive culture. PCR yielded a sensitivity of 93.8% and specificity of 99.1% 
for the diagnosis of TB, when diagnosis was confirmed by culture. There were 2 out of 32(6.3%) PCR-positive cases 
among the patients with non-TB disease. 
Conclusion: We concluded that the performance of an IS6110 PCR assay is valuable in the rapid diagnosis of 
tuberculosis. 
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INTRODUCTION  
1Tuberculosis is one of the most hideous 
infectious diseases which was declining for some 
decades, but is now on the rise alongside the 
appearance of AIDS. The World Health 
Organization estimates that if stronger measures 
are not taken up to control the prevalence of this 
disease, from 2000 to 2020 a billion people will be 
infected by the bacterium, 200 million of which 
will develop the disease and 35 million people will 
expire as a result. Currently, there are 
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approximately 8 million new infections and 3 
million deaths attributed to M. tuberculosis each 
year (1,2). Therefore, the WHO has declared 
tuberculosis a universal emergency. At the present 
time, the diagnosis of tuberculosis relies on Ziehl- 
Nielson staining and bacterial culture on 
Lowenstein-Johnson medium, taking 6-8 weeks. 
Using various techniques of PCR and multiplex 
PCR for detection of bacteria in clinical samples 
has aided the researchers and clinicians greatly (3). 
The gold standard in detecting M.tuberculosis is 
culture, considered the standard method by all 
references. 
Several rapid diagnostic modalities for the 
identification of mycobacteria have been 
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developed. The major advance was the detection of 
M. tuberculosis by nucleic acid amplification tests 
(NAT). These technologies are attractive because 
of the possibility of directly detecting 
M.tuberculosis in clinical respiratory specimens. 
PCR-based assays for the detection of M. 
tuberculosis approach the sensitivity and 
specificity of conventional culture but have the 
added advantage of being rapid (4). Unfortunately, 
because of the possibility of false-negative 
reactions among other reasons, the use of NAT for 
M. tuberculosis has come under scrutiny and their 
usefulness has been questioned (5). In addition, the 
Centers for Disease Control and Prevention (CDC) 
has suggested an algorithm for the use of these 
tests that includes repeat testing, which is costly 
and unattractive to the laboratory (5).  
Various loci have been utilized to diagnose M. 
tuberculosis, such as insertion sequence 6110, 
antigens 65KDa (Gro EL), 38 KDa (PhoS) and 23 
KDa (MPB64) (6). Among these, PCR of the 
IS6110 sequence showed the highest sensitivity 
compared to PCR of other gene loci (7). The 
repetition of this sequence increases the sensitivity 
of PCR which involves the amplification of a 
single DNA sequence. In other words, the single 
DNA has multiple segments to be proliferated, and 
thus the chance of primer binding increases even 
with small amounts of DNA. Furthermore, this 
segment occurs only in M. tuberculosis complex, 
and this is another advantage for using it in 
detecting M. tuberculosis (8,9). In some regions 
like India, strains lacking this segment have been 
reported, however many studies have never 
reported the lack of this segment in regions like 
Brazil (10,11).  
Considering the importance of rapidly 
diagnosing tuberculosis and the controversy 
concerning the sensitivity and specificity of PCR, 
we conducted this study to evaluate the sensitivity, 
specificity, positive predictive value, and negative 
predicative value of PCR in patients suspected of 
tuberculosis referring to Moslem Ben Aqil center, 
Kashan ,Iran, from May 2007 to August 2007. 
 
PATIENTS and METHODS 
This predictive value study was conducted on 
248 sputum samples from patients suspected of 
tuberculosis referring to Moslem Ben Aqil center, 
Kashan, Iran, from May 2007 to August 2007.The 
sputum samples were digested and disinfected 
using the standard procedure (12). Subsequently 
the samples were used for Ziehl-Nielson staining, 
culture and PCR. All the samples were cultured on 
Lowenstein Johnson medium and kept for eight 
weeks in 37°C, and the positive cultures were 
biochemically identified. The DNA in sputum 
samples was extracted through boiling. In this 
procedure, each sample was centrifuged twice at 
10000g and the precipitate was dissolved in 1mL 
sterile distilled water. Then, the solution was 
heated for 20 minutes at 85°C to simultaneously 
kill bacteria and extract DNA. In this study, one 
sample of M. tuberculosis (clinically isolated 
strain) was used as positive control.  
The PCR reaction was optimized by varying 
outer primer annealing temperature and primer 
concentration. The PCR was performed in 50µl of 
reaction mixture containing 10mM Tris-HCl (pH 
8.4), 50mM KCl, 2.5mM MgCl2, 15pmol each of 
primer and optimal concentration of dNTPs 
(SinaGENE, Tehran, Iran) and 1µl of 50 unit Taq 
DNA polymerase (SinaGENE, Tehran, Iran) and 
5µl of DNA extracted from sputum samples. 
The reaction mixture was initially denatured at 
94°C for 5 minutes, and subjected to 35 cycles of 
PCR comprising denaturation at 94ºC for 45 
seconds, annealing at 68ºC for 45 seconds and 
extension at 72ºC for 45 seconds. Finally, the PCR 
products were detected by electrophoresis of 5µl 
reaction mixture in 1.2% agarose gel and 
examination of the ethidium bromide-stained gel 
under a UV transilluminator (INGENIUS, 
SYNGENE).   
230  Detection of TB by PCR 
Iranian Journal of Clinical Infectious Disease 2009;4(4):228-232 
The primers for IS61610 included M1: 
5´CCTGCGAGCGTAGGCGTCGG3´ and M2: 
5´CTCGTCCAGCGCCGCTTCGG3´ for 
amplifying the 123 base pair segment, and 
C1:5´GCGTAGGCGTCGGTGACAAA3´and C2: 
5´CGTGAGGGCATCGAGGTGGC3´ for 
amplifying the 245 base pair segment (figure 1). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
RESULTS 
Of 248 sputum samples, 40 samples (16.1%) 
showed acid fast bacteria after Ziehl Nielson 
staining (positive smear) and 32 samples (12.9%) 
were culture positive on Lowenstein Johnson 
medium. 
  
Table 1. Detecting Mycobacterium tuberculosis in 
sputum samples using multiplex polymerase chain 
reaction (PCR) 
In this study, the occurrence of each band was 
considered positive PCR. Totally, 32 samples 
(12.9%) had positive PCR. Table 1 compares the 
culture, smear and PCR results. Table 2 presents 
the sensitivity, specificity, and negative and 
positive predictive values of PCR in comparison 
with culture. 
 
Table 2. Sensitivity, specificity, positive predictive 
value (PPV), negative predictive value (NPV) of 
polymerase chain reaction (PCR) and smear compared 
to culture 
NPVPPVSpecificity Sensitivity
99.1 93.899.1 93.8 PCR
100 80.096.2 100Smear
 
DISCUSSION 
Other studies from different regions of the 
world report 80-90% sensitivity for PCR, 
considering various DNA extraction methods (7). 
In our study all samples with positive smear and 
culture (except 6) had positive PCR result. From 32 
cases with positive PCR, 30 cases (93.75%) were 
corroborated by culture, and 22 cases (64.45%) 
were corroborated by both smear and culture. The 
sensitivity of the M. tuberculosis complex PCR 
ranged from 40.6% (95%CI:34.0–47.4) in 
microbiological positive pulmonary TB (PTB) 
patients to 66.7% (95%CI:47.1–82.1) in 
microbiological-negative PTB patients. The 
specificity of the test was 98.2% (95%CI:89.0–
99.9) in all categories. The PPV of the test was 
well above 95% in all categories. The NPV was 
much lower with values ranging from 29.5% 
(95%CI:23.1–36.8) in microbiological-positive 
PTB patients to 84.4% (95%CI:72.7–91.9) in 
microbiological-negative PTB patients (13). Querol 
et al (14) tested 314 respiratory samples using 
IS6110 primer and reported a sensitivity of 97% 
compared to culture. Thoe et al (15) in Singapore 
used IS6110 PCR and Amplicor to report 
sensitivity and specificity of 86.5% and 83.6%, 
respectively. In this study, the small amount of 
samples, using unequal samples, and lack of 
IS6110 segment are reasons that prevent the 
detection of M. tuberculosis. Christiane Schewe et 
al (16) showed that the highest sensitivity was 
achieved for the amplification of the IS6110 gene 
followed by the 16S rDNA of M. tuberculosis 
 
Figure 1. Amplification of DNA template isolated 
from sputum specimens using multiplex PCR. 
PCR was performed with isolated DNA of sputum 
specimens (lanes 2). The amplified product is 
shown as band of 123 bp and a band of 245 bp. 
Lane 1 is 100 bp DNA marker. 
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complex, whereas regarding specificity, the latter 
was superior to the IS6110 detection. 
In our study, we evaluated the performance of a 
test based on PCR amplification in sputum using 
the IS6110 sequence of M. tuberculosis complex as 
a target to be amplified. While evaluating the 
reproducibility of our M. tuberculosis complex 
PCR technique, we found that some samples had 
negative PCR results despite of positive culture 
(tow samples), this suggests that M. tuberculosis 
complex DNA is represented in low copy numbers 
and/or is unevenly distributed in sputum samples, 
as already suggested by others (17,18). 
In the light of these results, M. tuberculosis 
complex PCR should be recommended for routine 
detection of new TB patients in Kashan. The 
technique may, however, be useful for confirming 
M. tuberculosis in patients suspected to be 
microbiological-negative PTB when clinical and 
bacteriological diagnoses are not conclusive. 
Rapid diagnosis of tuberculosis may have 
profound effects in patients’ care. These effects 
may be considered from different aspects. In 
smear-positive patients with positive PCR, the 
etiology of the disease would be tuberculosis 
bacillus, and the patient must be cared for until the 
smear turns negative; but a negative PCR may 
indicate non tuberculosis mycobacterial infection; 
thus the patient must no longer undergo  
M. tuberculosis isolation procedures, and proper 
therapy should be initiated. The potential effects of 
this method in reducing the therapeutic costs are 
evident.  
It may be concluded that nucleic acid 
amplification methods corroborate positive smears, 
and in patients with clinically suspicious symptoms 
but negative smears, may account for the presence 
of M. tuberculosis. The recent guidelines of CDC 
verify this conclusion (19). In cases of negative 
smear, it is recommended to withhold initiation of 
therapy until the culture results are ready, because 
this condition bears a low risk of disease transfer. 
PCR, in diagnosis of tuberculosis, provide rapidity 
in gain of results but sensitivity and specificity of 
this method has not shown difference from smear 
and culture. In addition to the rapidity of molecular 
methods, such methods may be used directly in 
clinical and veterinary laboratories to enhance 
public health. Moreover, they may be helpful in 
diagnosing extra pulmonary infections of 
tuberculosis, particularly tuberculotic meningitis 
(20). 
The addition of specific primers for different 
species of mycobacterium, especially M. bovis, 
multiplex PCR may be used to distinguish various 
species of mycobacterium which cause diseases in 
man or animals.  
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